Reports have started circulating regarding a potential new hair loss “cure”, which could be available in as little as two years. This new treatment is built upon existing research regarding male pattern baldness, and an enzyme called PGD2. The discovery of PGD2’s role in hair loss has been documented for some time, but according to reports a new agreement between scientists and drug companies could see a potential treatment available for use by men and women within two years.
A team of scientists working at the University of Pennsylvania have discovered PGD2 plays a significant role in genetic hair loss, and that certain drugs commonly used to treat asthma and allergies inhibit its action on hair. Discussions are underway to arrange full-scale trials of these medications as potential hair loss treatment.
Two years is a long time to wait
Despite the excitement surrounding these new developments, it is worth noting that Dr Cotsarelis, who heads up the University research team, is still only in early negotiations with pharmaceutical manufacturers. There is also a heavy emphasis on the word “could” when discussing the two year timescale to launch, suggesting it could be considerably longer before this new hair loss treatment is made widely available.
Worth believing the hype?
It seems every 6 months or so a front-page story is published detailing a potential revolutionary cure for baldness. Below are four similar stories from the past 18 months, proving such stories shouldn’t be taken so seriously, especially since there are already a number of treatments available that are extremely effective in preventing hair loss and regrowing hair and at this time there is no strong evidence to indicate that these potential treatments would be any better.
Treating hair loss now
Although PGD2 inhibitors are an exciting development, there are already medically proven treatments available which slow hair loss and promote natural regrowth.
As a consequence, there is no reason why any man or woman experiencing hair loss need delay treatment in advance of the release of Dr Cotsarelis’ new drug. In fact, our experience suggests that the sooner people experiencing pattern balding begin treatment, the better the chance of significant regrowth.
No more uncertainty
Despite the findings at the University of Pennsylvania, Dr Cotsarelis remains remarkably reserved about the potential of his PGD2 blocker as a true hair loss treatment. “We certainly think it would be good at preventing hair loss,” Cotsarelis said in an interview with the Daily Mail, “but we don’t know for sure that it would regrow.”
The Belgravia Centre has a number of custom revolutionary treatments of its own, which have been created for the specific needs of our clients. These extra strength variants of minoxidil are unique to The Belgravia Centre, and by combining MPG, azelaic acid or caffeine (which are known to stimulate the actions of certain cells), are used for treating stubborn hair loss conditions such as extensive cases of Male Pattern Baldness. Our success stories are visual evidence of the exceptional results so many patients experience.
So why not contact us online or call us today on 0800 077 6666 to arrange a free, no obligation consultation with one of our hair loss experts? We can get started on your personalized treatment plan right away. If you can’t make it into our clinic, we can still help – simply complete our online diagnostic form for a home use treatment programme that we can send to you in the post.